SEC Form 4 · accession 0001493152-15-002240
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim Giffoni
Officer — Chief Financial Officer · Director · 10% Owner
Period of report
May 20, 2015
Accepted (ET)
May 26, 2015 · 6:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 20, 2015 | A | 68,077 | $0.20 | A | 144,098 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Share issuance was in lieu of salary and issued at a value of $0.20 per share.